Autopsy report · NCT01434511
Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 10 months before it stopped.
- 1 participant enrolled.
- Results were posted on the registry 1 year 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Baxalta now part of Shire
- Sponsor type
- Industry
- Conditions
- Hemophilia A
- Interventions
- OBI-1
- Participants
- 1
- Sites
- 3
- Countries
- South Africa, United Kingdom, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.